InvestorsHub Logo
Followers 78
Posts 11422
Boards Moderated 0
Alias Born 04/03/2014

Re: None

Thursday, 08/30/2018 11:24:03 AM

Thursday, August 30, 2018 11:24:03 AM

Post# of 3833
Cancer cohort news coming?

This is not NASH impact in my view. For NASH they need partner to start trial.

If Cohort 3 ORR is as good - this becomes cancer play and BO target for Merck or BMY
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent GALT News